Thrivent Financial for Lutherans
GBIO

Thrivent Financial for Lutherans’s Generation Bio GBIO Stock Holding History

Thrivent Financial for Lutherans’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,984
Closed -$146K – 2454
2022
Q1 		$146K Buy
+1,984
New +$115K ﹤0.01% 2466
2021
Q3 		– Sell
-1,102
Closed -$296K – 2480
2021
Q2 		$296K Buy
+1,102
New +$330K ﹤0.01% 2335

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans's GBIO Position: Q2 2022 in Review

Thrivent Financial for Lutherans sold out of Generation Bio (GBIO) in Q2 2022, closing a stake of 1,984 shares — an estimated $146K sold.

Thrivent Financial for Lutherans first reported a position in GBIO in Q2 2021 and held it in 2 quarters. The position peaked at $296K in Q2 2021. 91 funds tracked by Wall St. Rank hold GBIO as of Q2 2022.

  • Thrivent Financial for Lutherans reported no remaining Generation Bio position as of Q2 2022 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 1,984 Generation Bio shares in Q2 2022, an estimated $146K.
  • Thrivent Financial for Lutherans first reported a position in Generation Bio in Q2 2021 and held it in 2 quarters.
  • Thrivent Financial for Lutherans's Generation Bio position peaked at $296K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Generation Bio as of Q2 2022.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2022, filed 16 Aug 2022.